You are here

Article metrics

Article menu
Immunotherapy biomarkers
Original research
ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer

 

Online download statistics by month:

Online download statistics by month: February 2023 to August 2024

AbstractFullPdf
Feb 202321621877
Mar 2023250256135
Apr 202312212257
May 2023999941
Jun 2023838630
Jul 202310110145
Aug 202315515552
Sep 202312212553
Oct 202311011359
Nov 2023939335
Dec 2023767745
Jan 202410110178
Feb 2024686860
Mar 2024888875
Apr 2024868674
May 2024707349
Jun 2024666853
Jul 2024828451
Aug 20244745112
Total203520581181